Faes Farma, S.A. (LON:0K9H)

Market Cap	1.26B +10.1%
Revenue (ttm)	588.57M +28.6%
Net Income	71.63M -24.9%
EPS	0.23
Shares Out	n/a
PE Ratio	17.58
Forward PE	14.57
Dividend	0.13 (2.63%)
Ex-Dividend Date	Jan 8, 2026

Volume	431
Average Volume	7,050
Open	4.800
Previous Close	4.804
Day's Range	4.690 - 4.775
52-Week Range	4.123 - 5.480
Beta	0.34
RSI	43.66
Earnings Date	Apr 30, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securiti...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 2,679
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0K9H

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.

Financial numbers in EUR